
Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Homer Macapinlac, MD is a board certified nuclear medicine physician in Houston, Texas. He is currently licensed to practice medicine in Texas and New York. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 1989 - 1994
New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Pathology-Anatomic and Clinical, 1987 - 1989
University of the East College of MedicineClass of 1983
Certifications & Licensure
TX State Medical License 2002 - 2027
NY State Medical License 1994 - 2021
American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Publications & Presentations
PubMed
- 1 citationsAssessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis.Kalevi Kairemo, Homer A Macapinlac, Mohammed Gouda, Vivek Subbiah
Diagnostics. 2024-08-28 - 1 citationsDeciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors.Kalevi Kairemo, Mohamed Gouda, Hubert H Chuang, Homer A Macapinlac, Vivek Subbiah
Journal of Clinical Medicine. 2024-05-31 - 411 citationsSafety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19B cell tumors: a phase 1/2 trial.David Marin, Ye Li, Rafet Basar, Hind Rafei, May Daher
Nature Medicine. 2024-03-01